| Total (%) |
---|---|
Regiona | |
 Sub-Saharan Africa | 18 (62%) |
 East Asia and Pacific | 5 (17%) |
 South Asia | 3 (10%) |
 Middle East and North Africa | 2 (7%) |
 Europe and Central Asia | 1 (3%) |
 Latin America and the Caribbean | 1 (3%) |
Associated health conditiona | |
 HIV/AIDS | 20 (69%) |
 Mental health | 3 (10%) |
 Leprosy | 2 (7%) |
 Sexually transmitted infections | 2 (7%) |
 Tuberculosis | 1 (3%) |
 Epilepsy | 1 (3%) |
 Podoconiosis | 1 (3%) |
 Lymphatic filariasis | 1 (3%) |
Intervention typea | |
 Information/Education | 28 (97%) |
 Skills | 13 (45%) |
 Counselling/Support | 6 (21%) |
 Contact | 6 (21%) |
 Structural | 1 (3%) |
 Biomedical | 1 (3%) |
Target stigma domaina | |
 Driver | 28 (97%) |
 Facilitator | 4 (14%) |
 Manifestation | 10 (34%) |
Target stigma typea | |
 Community | 24 (83%) |
 Experienced | 11 (38%) |
 Internalized | 9 (31%) |
 Anticipated | 7 (24%) |
Intervention levela | |
 Individual | 23 (79%) |
 Interpersonal | 14 (48%) |
 Organizational | 6 (21%) |
 Community | 11 (38%) |
 Public Policy | 1 (3%) |
TIDieR intervention specification | |
 Mean reporting score (SD) | 60% (10%) |
 Why | 28 (97%) |
 What materials | 25 (86%) |
 What procedures | 28 (97%) |
 Who provided | 25 (86%) |
 How | 29 (100%) |
 Where | 27 (93%) |
 When and how much | 26 (90%) |
 Tailoring | 5 (17%) |
 Modifications | 2 (7%) |
 How fidelity was assessed | 4 (14%) |
 Level of fidelity | 3 (10%) |